DNMT1 and breast carcinoma: Inactivation of the TGFβ/SMAD pathway has been shown to inhibit cell invasion by suppressing DNMT1 and claudin-6 methylation and expression in MCF-7 and SKBR-3 breast cancer cell lines [29].